• ABPI Website
  • Media
  • ABPI responds to Government coronavirus testing ‘call to arms’

ABPI responds to Government coronavirus testing ‘call to arms’

The UK Government has put out a ‘call to arms’ to the life sciences industry to help them rapidly develop coronavirus testing as part of the Health Secretary’s pledge to carry out 100,000 tests a day by the end of April.

Today’s call to action is another example of how the industry is coming together to use the breadth of our expertise to step up to the challenge to meet the Government’s ambitious target.   Richard Torbett

Responding on behalf of the UK pharmaceutical industry, Richard Torbett, Chief Executive of the ABPI, said:

“The Secretary of State for Health has set out a clear goal to rapidly increase the number of patients, NHS staff and key workers that can get tested quickly and safely.

"The pharmaceutical industry is playing the biggest possible role in the fight against COVID-19 and a huge amount of work is already happening to research new medicines and vaccines and develop new diagnostics.

"Today’s call to action from the Government is another example of how the industry is coming together to use the breadth of our expertise to step up to the challenge to meet the Government’s ambitious target.”

TAGS
  • COVID 19

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.